Capstone Asset Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-108
| Closed | -$272K | – | 1611 |
|
|
2017
Q1 | $272K | Buy |
108
+7
| +7% | +$17.6K | 0.01% | 1360 |
|
|
2016
Q4 | $229K | Sell |
101
-31
| -23% | -$70.3K | 0.01% | 1496 |
|
|
2016
Q3 | $332K | Sell |
132
-2
| -1% | -$5.03K | 0.01% | 1255 |
|
|
2016
Q2 | $409K | Buy |
134
+11
| +9% | +$33.6K | 0.01% | 1083 |
|
|
2016
Q1 | $392K | Sell |
123
-2
| -2% | -$6.37K | 0.01% | 1079 |
|
|
2015
Q4 | $641K | Buy |
125
+13
| +12% | +$66.7K | 0.02% | 767 |
|
|
2015
Q3 | $357K | Buy |
112
+7
| +7% | +$22.3K | 0.01% | 1128 |
|
|
2015
Q2 | $420K | Sell |
105
-59
| -36% | -$236K | 0.01% | 1076 |
|
|
2015
Q1 | $654K | Buy |
164
+6
| +4% | +$23.9K | 0.02% | 909 |
|
|
2014
Q4 | $776K | Sell |
158
-70
| -31% | -$344K | 0.02% | 766 |
|
|
2014
Q3 | $927K | Buy |
228
+2
| +0.9% | +$8.13K | 0.03% | 615 |
|
|
2014
Q2 | $916K | Buy |
226
+27
| +14% | +$109K | 0.03% | 657 |
|
|
2014
Q1 | $907K | Sell |
199
-2
| -1% | -$9.12K | 0.03% | 663 |
|
|
2013
Q4 | $705K | Sell |
201
-11
| -5% | -$38.6K | 0.02% | 851 |
|
|
2013
Q3 | $869K | Buy |
212
+5
| +2% | +$20.5K | 0.02% | 855 |
|
|
2013
Q2 | $820K | Buy |
+207
| New | +$820K | 0.02% | 827 |
|